Literature DB >> 17108262

Multidrug-resistant pulmonary infection in cystic fibrosis--what does 'resistant' mean?

J R W Govan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108262     DOI: 10.1099/jmm.0.46884-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  6 in total

Review 1.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection.

Authors:  Samuel M Moskowitz; Julia C Emerson; Sharon McNamara; Richard D Shell; David M Orenstein; Daniel Rosenbluth; Marcia F Katz; Richard Ahrens; Douglas Hornick; Patricia M Joseph; Ronald L Gibson; Moira L Aitken; Wade W Benton; Jane L Burns
Journal:  Pediatr Pulmonol       Date:  2010-10-20

Review 3.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Authors:  M C Gaspar; W Couet; J-C Olivier; A A C C Pais; J J S Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

Review 4.  New antimicrobial strategies in cystic fibrosis.

Authors:  Mireille van Westreenen; Harm A W M Tiddens
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

5.  Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  Lucie Vettoretti; Patrick Plésiat; Cédric Muller; Farid El Garch; Gilles Phan; Inna Attrée; Arnaud Ducruix; Catherine Llanes
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

6.  Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation.

Authors:  Claire L Keating; Jonathan B Zuckerman; Pradeep K Singh; Matthew McKevitt; Oksana Gurtovaya; Mark Bresnik; Bruce C Marshall; Lisa Saiman
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.